The findings revealed suppressed expression of CXCL12 chemokine in the livers of individuals with T1DM, while treatment with NAC induced specific activation of CXCL12 within the liver affected by T1DM. The gene discussed is CXCL12; the disease is type 1 diabetes mellitus.